Walleye Capital’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
Other funds holding RLAY
Walleye Capital's RLAY Position: Q3 2026 in Review
Walleye Capital opened a new position in Relay Therapeutics (RLAY) in Q3 2026: 100 shares worth $1.8K. The stake represents ﹤0.01% of the portfolio and ranks #5848 among its holdings. This is a return to the name: Walleye Capital previously reported a position in RLAY as recently as Q1 2025.
Walleye Capital first reported a position in RLAY in Q3 2022 and has held it in 8 quarters since. The position peaked at $12.9M in Q3 2024. 261 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.
- Walleye Capital held 100 shares of Relay Therapeutics worth $1.8K as of Q3 2026.
- Relay Therapeutics was a new Walleye Capital position in Q3 2026.
- Relay Therapeutics made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5848 holding.
- Walleye Capital first reported a position in Relay Therapeutics in Q3 2022 and has held it in 8 quarters since.
- Walleye Capital's Relay Therapeutics position peaked at $12.9M in Q3 2024.
- 261 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.